Tech Company Financing Transactions
Virobay Funding Round
Virobay closed a $8 million Series B funding round on 7/17/2014. Investors included AbbVie Biotech Ventures, Alta Partners and Perceptive Advisors.
Transaction Overview
Company Name
Announced On
7/17/2014
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series B
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1360 Willow Rd. 100
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
Virobay Inc is a virtual pharmaceutical development company. We find promising small molecule compounds in early or late leadoptimization and complete all necessary studies required toachieve a clinical proof-of-concept.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Booth
VP - Manufacturing
Anantha Sudhakar
Browse more venture capital transactions:
Prev: 7/17/2014: PredictionIO venture capital transaction
Next: 7/17/2014: SalutarisMD venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs